Clobetasol promotes remyelination in a mouse model of neuromyelitis optica

Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system that can produce marked neurological deficit. Current NMO therapies include immunosuppressants, plasma exchange and B-cell depletion. Here, we evaluated 14 potential remyelinating drugs emerging from pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Xiaoming, Su, Tao, Verkman, A. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845317/
https://www.ncbi.nlm.nih.gov/pubmed/27117475
http://dx.doi.org/10.1186/s40478-016-0309-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845317/
https://www.ncbi.nlm.nih.gov/pubmed/27117475
http://dx.doi.org/10.1186/s40478-016-0309-4

Ejemplares similares